Showing results (11-20 of 27) with videos related to
Sort By:
Pageof 3
Cancer Research|March 27, 1998
Molecular mediators of angiogenesis in bladder cancerS C Campbell, O V Volpert, M Ivanovich, et al.Nature Medicine|December 29, 1999
Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1B Jiménez, O V Volpert, S E Crawford, et al.Oncogene|June 26, 2001
c-Jun N-terminal kinase activation is required for the inhibition of neovascularization by thrombospondin-1B Jiménez, O V Volpert, F Reiher, et al.Genes & Development|June 8, 2001
In vivo mechanisms by which tumors producing thrombospondin 1 bypass its inhibitory effectsS Filleur, O V Volpert, A Degeorges, et al.The Journal of Cell Biology|July 1, 1993
Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activityS S Tolsma, O V Volpert, D J Good, et al.Science (New York, N.Y.)|July 10, 1999
Pigment epithelium-derived factor: a potent inhibitor of angiogenesisD W Dawson, O V Volpert, P Gillis, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 29, 2000
Sphingosine 1-phosphate released from platelets during clotting accounts for the potent endothelial cell chemotactic activity of blood serum and provides a novel link between hemostasis and angiogenesisD English, Z Welch, A T Kovala, et al.Biochemical and Biophysical Research Communications|December 5, 1995
Inhibition of angiogenesis by thrombospondin-2O V Volpert, S S Tolsma, S Pellerin, et al.Journal of Cell Science|May 26, 1999
Keratinocyte growth factor induces angiogenesis and protects endothelial barrier functionP Gillis, U Savla, O V Volpert, et al.The Journal of Experimental Medicine|September 22, 1998
Inhibition of angiogenesis by interleukin 4O V Volpert, T Fong, A E Koch, et al.Pageof 3